Form4insider filings, from the source

Insider holders · CIK 0001513525

ADIAL PHARMACEUTICALS, INC. · ADIL

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
William B. Stilley IIIChief Executive Officer504,000132,141636,141Aug 2, 2018 · 4:14 pm EDTForm 4
Coastlands Capital LP10% Owner—388,308388,308Jul 16, 2026 · 5:08 pm EDTForm 4
Kevin SchuylerDirector343,3903,042346,432Aug 2, 2018 · 4:11 pm EDTForm 4
Robertson H. GillilandDirector—109,424109,424Aug 2, 2018 · 4:03 pm EDTForm 4
Joseph TruluckChief Financial Officer80,555—80,555Aug 2, 2018 · 4:16 pm EDTForm 4
James W. Newman Jr.Director10,00010,00020,000Aug 2, 2018 · 4:10 pm EDTForm 4
Tony GoodmanDirector8,755—8,755Aug 2, 2018 · 4:06 pm EDTForm 4
Matt DavidsonChief Development Officer1,8221,9233,746Jun 16, 2026 · 6:36 am EDTForm 4
En Fidecomiso de Mi Vida 11/23/2010 Trust10% Owner1,4009302,330Aug 2, 2018 · 4:08 pm EDTForm 4
Bankole A. JohnsonDirector1,4009302,330Aug 2, 2018 · 4:08 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.